KL and chronic obstructive pulmonary disease: Klotho can also inhibit the nuclear translocation of NF-κB and the expression of downstream genes, reducing the release of inflammatory mediators such as interleukin-6 and tumor necrosis factor-alpha, thereby alleviating airway inflammation in COPD and asthma patients [60].